CS logo
small CS logo
C.I.C. Mauricie

Trois Rivieres, Quebec, Canada

About C.I.C. Mauricie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at C.I.C. Mauricie


During the past decade, C.I.C. Mauricie conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "C.I.C. Mauricie" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Regeneron Pharmaceuticals" with 1 trials sponsored and "Verona Pharma plc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "C.I.C. Mauricie" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at C.I.C. Mauricie


According to Clinical.Site data, the most researched conditions in "C.I.C. Mauricie" are "Asthma" (3 trials), "Chronic Cough" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Allergic Rhinitis Due to Cat Allergy" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "C.I.C. Mauricie" in a lesser frequency.

Clinical Trials Intervention Types at C.I.C. Mauricie


Most popular intervention types in "C.I.C. Mauricie" are "Drug" (11 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Ensifentrine" (1 trials) and "Gefapixant" (1 trials). Other intervention names were less common.

Clinical Trials Genders at C.I.C. Mauricie


The vast majority of trials in "C.I.C. Mauricie" are 12 trials for "All" genders.

Clinical Trials Status at C.I.C. Mauricie


Currently, there are NaN active trials in "C.I.C. Mauricie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in C.I.C. Mauricie, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in C.I.C. Mauricie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".